FLCN Antikörper (AA 1-130)
Kurzübersicht für FLCN Antikörper (AA 1-130) (ABIN7267226)
Target
Alle FLCN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-130
-
Verwendungszweck
- FLCN Rabbit pAb
-
Sequenz
- MNAIVALCHF CELHGPRTLF CTEVLHAPLP QGDGNEDSPG QGEQAEEEEG GIQMNSRMRA HSPAEGASVE SSSPGPKKSD MCEGCRSLAA GHPGYISHDK ETSIKYVSHQ HPSHPQLFSI VRQACVRSLS
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-130 of human FLCN (NP_653207.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- FLCN (Folliculin (FLCN))
-
Andere Bezeichnung
- FLCN
-
Substanzklasse
- Amino Acid
-
Hintergrund
- This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms.,FLCN,BHD,FLCL,Cancer,Tumor suppressors,Signal Transduction,PI3K-Akt Signaling Pathway,Regulator of mTOR complex function,FLCN
-
Molekulargewicht
- 20kDa/37kDa/64kDa
-
Gen-ID
- 201163
-
UniProt
- Q8NFG4
-
Pathways
- Cell-Cell Junction Organization
Target
-